优化NIV医保覆盖:低通气综合征患者的技术专家小组报告
美国胸科医师学会等四家学会的技术专家小组指出,现有家庭无创通气(NIV)覆盖标准未反映低通气综合征的多样性和技术进展,识别出六项主要覆盖障碍,并基于随机对照试验证据和临床实践指南提出五项关键建议,以改善患者及时获得NIV治疗。
要点
- 现有家庭NIV覆盖标准未反映低通气综合征多样性及技术进展。
- 建议接受替代性无创Pco2监测(呼气末、经皮)及静脉血气替代动脉血气。
- 建议取消处方氧疗时测Pco2、睡眠研究、肺功能及无备用频率BPAP失败等要求。
核心结论
- 采用所提建议可为合适的低通气综合征患者及时提供合适的家庭NIV设备。
研究设计与样本
- 美国胸科医师学会、美国呼吸治疗协会、美国睡眠医学会和美国胸科学会联合召集的低通气综合征技术专家小组工作报告。
主要发现
- 识别出的最紧迫覆盖障碍包括:过度依赖动脉血气(尤其睡眠期间)、需在处方氧疗时进行检测、需睡眠研究排除OSA作为持续低氧血症原因、需肺功能检查、需证明无备用频率BPAP失败才能获批BPAP spontaneous/timed、以及住院患者出院时获得家庭NIV资格。
- 支持政策变化的关键证据包括随机对照试验证据和临床实践指南。
关键数值与推荐
- 建议接受替代性无创呼气末和经皮Pco2及静脉血气替代动脉血气。
- 不建议要求处方氧疗时测Pco2。
- 不建议要求睡眠研究以避免出院患者护理延迟。
- 建议取消肺功能检查要求。
- 不建议要求无备用频率BPAP失败才能批准BPAP spontaneous/timed。
临床怎么用
- 临床医生可依据这些建议为低通气综合征患者(尤其肥胖低通气综合征)申请家庭NIV时减少不必要的检测障碍。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The existing coverage criteria for home noninvasive ventilation (NIV) do not recognize the diversity of hypoventilation syndromes and advances in technologies. This document summarizes the work of the hypoventilation syndromes Technical Expert Panel working group. The most pressing current coverage barriers identified were: (1) overreliance on arterial blood gases (particularly during sleep); (2) need to perform testing on prescribed oxygen; (3) requiring a sleep study to rule out OSA as the cause of sustained hypoxemia; (4) need for spirometry; (5) need to show bilevel positive airway pressure (BPAP) without a backup rate failure to qualify for BPAP spontaneous/timed; and (6) qualifying hospitalized patients for home NIV therapy at the time of discharge. Critical evidence support for changes to current policies includes randomized controlled trial evidence and clinical practice guidelines. To decrease morbidity and mortality by achieving timely access to NIV for patients with hypoventilation, particularly those with obesity hypoventilation syndrome, we make the following key suggestions: (1) given the significant technological advances, we advise acceptance of surrogate noninvasive end-tidal and transcutaneous Pco2 and venous blood gases in lieu of arterial blood gases; (2) not requiring Pco2 measures while on prescribed oxygen; (3) not requiring a sleep study to avoid delays in care in patients being discharged from the hospital; (4) remove spirometry as a requirement; and (5) not requiring BPAP without a backup rate failure to approve BPAP spontaneous/timed. The overarching goal of the Technical Expert Panel is to establish pathways that improve clinicians' management capability to provide Medicare beneficiaries access to appropriate home NIV therapy. Adoption of these proposed suggestions would result in the right device, for the right type of patient with hypoventilation syndromes, at the right time.
引用
- Mokhlesi B, Won CH, Make BJ, et al. Optimal NIV Medicare Access Promotion: Patients With Hypoventilation Syndromes: A Technical Expert Panel Report From the American College of Chest Physicians, the American Association for Respiratory Care, the American Academy of Sleep Medicine, and the American Thoracic Society. Chest. 2021. PMID: 34339686. doi:10.1016/j.chest.2021.06.083
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。